Segments - Biotechnology Instrumentation Market by Technology (Imaging, Laboratory Automation, Electrophoresis [Capillary and Gel], Microarray Technology [Cells, DNA, Tissue, and Protein], Immunoassay [Chemiluminescence, Radio, Fluorescence, and Enzyme], Mass Spectroscopy [Atomic, Molecular, and Mass], Chromatography [Gas and Liquid]), End-users (Pharmaceutical Companies, Biotech Companies, and Research Institutes), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023-2031
The global biotechnology instrumentation market size was USD 86.28 Billion in 2022 and is projected to reach USD 122.17 Billion by 2031 register a significant CAGR 3.94% during the forecast period, 2023-2031. The growth of the market is attributed to the increasing need for biotechnological tools in the pharmaceutical industry, biotech industry, and several other medical-related industries.
Biotechnology is a dynamic and ever-growing field where it has wide applications of various products especially in the pharmaceutical industry and scientific research institutes. These products are mainly produced by using biological agents or their derivatives. Biotechnology instrumentation consists of essential and basic tools that are used to calculate, measure, utilize, and prepare biological samples or solutions.
In applied science, biotechnology is one of the most dynamic and researched fields at present. Some of the major and commonly used biotechnology tools or equipment are thermal cyclers, centrifuges, bioreactors, incubators, stability chambers, conductivity meters, spectrophotometers, and thermometers.
The report on the global biotechnology instrumentation market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Biotechnology Instrumentation Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Technology (Imaging, Laboratory Automation, Electrophoresis [Capillary and Gel], Microarray Technology [Cells, DNA, Tissue, and Protein], Immunoassay [Chemiluminescence, Radio, Fluorescence, and Enzyme], Mass Spectroscopy [Atomic, Molecular, and Mass], Chromatography [Gas and Liquid]), End-Users (Pharmaceutical Companies, Biotech Companies, and Research Institutes) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Waters Corp.; Agilent Technologies, Inc.; Becton, Dickinson and Co.; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; Shimadzu Corp.; F. Hoffmann-La Roche Ltd.; Eppendorf; Bruker Corp.; Spinco biotech Ltd.; Sigma Aldrich; Danaher Corp., and Thermo Fisher Scientific, Inc. |
On the basis of technology, the global biotechnology instrumentation market is segmented into imaging, laboratory automation, electrophoresis, microarray technology, immunoassay, mass spectroscopy, and chromatography. The electrophoresis segment is further bifurcated into capillary and gel electrophoresis.
The microarray technology segment is sub-divided into cells, DNA, tissue, and protein while the immunoassay segment is further segmented into chemiluminescence, radio, fluorescence, and enzyme. The mass spectroscopy is sub-divided into atomic, molecular, and mass while the chromatography is further bifurcated into gas and liquid. The imaging segment is expected to dominate the market during the forecast period attributed to various applications of instrumentation.
Based on end-users, the market is categorized as pharmaceutical companies, biotech companies, and research institutes. The pharmaceutical companies segment is anticipated to hold a major share of the market in the coming years owing to the increasing usage of biotechnological tools or instruments by pharmaceutical companies for the development of new drugs and devices for diseases treatment.
In terms of regions, the global biotechnology instrumentation market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is estimated to exhibit a high CAGR during the forecast period attributed to the enormous amount of funding made by major pharmaceutical players and ample amount of research & development initiatives by governments in the region.
Meanwhile, the market of Asia Pacific is expected to account for a considerable market share during the forecast period due to growing engagement by the pharmaceutical and biotech companies for the development of such products in the region. Moreover, increasing number of Contract Research Organizations (CROs) and support & fund provided by several governments to develop the pharmaceutical industry in the region.
The global biotechnology instrumentation market has been segmented on the basis of
Key players competing in the global biotechnology instrumentation market are Waters Corp.; Agilent Technologies, Inc.; Becton, Dickinson and Co.; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; Shimadzu Corp.; F. Hoffmann-La Roche Ltd.; Eppendorf; Bruker Corp.; Spinco biotech Ltd.; Sigma Aldrich; Danaher Corp., and Thermo Fisher Scientific, Inc.
Many of these players have adopted business strategies such as launch of new products, advancement of technologies, partnerships, mergers, and production capacity expansion in order to increase their consumer base and expand market position globally.